Press release
Genomic Biomarkers Market Growth and Status Explored in a New Research Report
Genomic Biomarkers Market
Get PDF Sample Report + All Related Table and Graphs @: https://www.theinsightpartners.com/sample/TIPRE00016646/?utm_source=OpenPR&utm_medium=10129
The rising burden of chronic diseases (cardiovascular diseases, cancer, strokes, and arthritis), high demand for minimally invasive procedures, and technological advancements will spur the demand of the genomic biomarkers market. However, high cost, complex development process, stringent government regulations and lack of standardized means to validate the marker may restraint the growth of the market in the forecasted period. Additionally, development in R&D, and the infrastructure for data sharing and the demand for personalized medicines will boost the growth of the market in the forecasted period.
Genomic Biomarkers Market: Competitive Landscape and Key Developments:
• Thermo Fisher Scientific
• F. Hoffmann-La Roche Ltd
• Aepodia
• Myriad Genetics, Inc
• Eurofins Scientific
• QIAGEN
• Bio-Rad Laboratories, Inc
• Exact Sciences Corporation
• Liquid Genomics, Inc,
• Epigenomics
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Ankit Mathur
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Genomic Biomarkers Market Growth and Status Explored in a New Research Report here
News-ID: 3364893 • Views: …
More Releases from The Insight Partners
Calcium Carbide Industry Advances with Strategic Expansions, Sustainable Innovat …
The Calcium Carbide Industry is experiencing a period of strategic evolution, driven by robust industrial demand, technological innovation, and regulatory shifts shaping production and applications across global markets. As a critical industrial chemical, calcium carbide continues to play an indispensable role in sectors such as metallurgy, chemicals, welding, and infrastructure development, with recent developments underscoring the industry's dynamic growth trajectory.
Check valuable insights in the Calcium Carbide Market report. You can…
Cytiva Pioneers Next-Generation Chromatography Resin Advancements for Biopharma …
United States of America - January 09, 2025 - According to The Insight Partners, The Chromatography Resin Market size is expected to reach US$ 4,224 million by 2031. The market is anticipated to register a CAGR of 7.3% during 2025-2031. Cytiva (Danaher Corporation) today announced breakthrough innovations in chromatography resin technology, designed to streamline purification processes for pharmaceutical and biotechnology companies worldwide. This development addresses key challenges in bioprocessing, enhancing…
Cardiopulmonary Exercise Testing Market Poised for Steady Expansion Through 2031 …
United States of America - January 09, 2025 - According to The Insight Partners, The Cardiopulmonary Exercise Testing Market is expected to register a CAGR of 7.33% from 2025 to 2031. The Cardiopulmonary Exercise Testing market continues to gain momentum as healthcare providers worldwide prioritize advanced diagnostic tools for cardiovascular and pulmonary conditions. This non-invasive testing method, often referred to as cardiopulmonary exercise testing (CPET), evaluates heart and lung performance…
Global Medical Robots Market Poised for Transformational Growth Through 2033
The Medical Robots Market continues to redefine modern healthcare delivery, driven by rapid technological advancements, expansion of minimally invasive surgical procedures, and growing adoption of autonomous support systems in clinical settings. As medical robotics technology evolves, the industry is experiencing heightened interest from hospitals, surgical centers, and healthcare innovators seeking to improve precision, reduce errors and transform patient outcomes.
Recent industry developments - including expanded robotics research units and novel product…
More Releases for Genomic
Genomic Cancer Testing Market Insights on the Impact of Genomic Profiling and Bi …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Genomic Cancer Testing Market - (By Test Type (Genomic Profiling Tests, Liquid Biopsy Tests, Companion Diagnostic Tests, Pharmacogenomic Tests, Hereditary Cancer Tests, Other specialized genomic tests), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Ovarian Cancer, Melanoma, Leukemia, Lymphoma, Other specific cancer types), By Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR),…
Japan Genomic Medicine Market 2025 | Hospitals & clinics lead with 53% share, ad …
Leander, Texas and Tokyo, Japan - Nov.27.2025
As per DataM intelligence research report" Japan Genomic Medicine Market to expected to grow at High CAGR during forecast period 2024-2031." Personalized treatment approaches and advanced research investments are boosting genomic medicine adoption in Japan.
Download your exclusive sample report today: (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/japan-genomic-medicine-market?Prasad
Japan: Recent Industry Developments
✅ In November 2025, Takeda Pharmaceutical advanced genomic-guided therapies for rare hereditary diseases, improving precision in…
Genomic and Epigenomic Profiling Market Development Driven by Investment in Biot …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Genomic & Epigenomic Profiling Market Size, Share & Trends Analysis Report, By Type (Genomic Profiling and Epigenomic Profiling), By Application (Clinical Diagnostics, Agriculture & Animal Research, and Drug Discovery & Development), By Technology (NGS, PCR-based, and Microarray), By End-use (Hospitals, Pharmaceuticals, and Research Institutes),-Market Outlook And Industry Analysis 2034"
Genomic & Epigenomic Profiling Market Size is…
Emerging Trends Influencing The Growth Of The Genomic Biomarker Market: Technolo …
The Genomic Biomarker Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
How Big Is the Genomic Biomarker Market Size Expected to Be by 2034?
The size of the genomic biomarker market has witnessed swift expansion in the recent past. It is slated to expand from a…
Genomic Biomarker Market Future Business Opportunities 2025-2032 | Liquid Genomi …
Latest Report, titled "Genomic Biomarker Market" Trends, Share, Size, Growth, Opportunity and Forecast 2025-2032, by Coherent Market Insights offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
The report features a comprehensive table of contents, figures, tables, and charts, as well as insightful analysis. The Genomic Biomarker market has been expanding significantly…
Lipid-Nanoparticle Based Genomic Medicines Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Lipid-Nanoparticle Based Genomic Medicines Market - (By Type (Liposome-based Nanoparticles, Micelle-based Nanoparticles, Lipid-Coated Nanoparticles), By Application (Cancer Treatment, Infectious Diseases, Genetic Disorders, Cardiovascular Diseases, Others), By Therapeutic Payload (mRNA-based Therapeutics, siRNA-based Therapeutics, miRNA-based Therapeutics, Other Genomic Medicines), By End-User (Hospitals, Biopharmaceutical Companies, Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the…
